查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1782024

甲状腺癌诊断市场（按产品、类型、技术、最终用户、国家和地区）－2025 年至 2032 年全球产业分析、市场规模、市场份额及预测

Thyroid Cancer Diagnostics Market, By Product, By Type, By Technique, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 392 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年甲状腺癌诊断市场规模价值 31.6724 亿美元，2025 年至 2032 年的复合年增长率为 5.5%。

甲状腺癌诊断市场-市场动态

预计甲状腺癌盛行率的上升将推动市场的成长。

随着甲状腺癌发生率的持续上升，对早期精准诊断方案的需求也显着增加。这一发展趋势促使人们更广泛地采用先进的影像方法、分子诊断和微创活检技术，这些技术对于有效的疾病识别、分类和製定治疗策略至关重要。美国每年约有53,000人被诊断出罹患甲状腺癌。大多数甲状腺癌患者的治疗效果良好。然而，每年仍有约2,000人死于该疾病。此外，医疗保健支出和筛检计划的增加为市场带来了成长机会。然而，先进诊断工具的高成本对市场扩张构成了挑战。

甲状腺癌诊断市场—关键见解

根据我们的研究分析师的分析，预计全球市场在预测期内（2025-2032 年）的年复合成长率约为 5.5%。

根据产品细分，预计仪器将在 2024 年占据最大市场份额

根据类型细分，乳头状癌是 2024 年的主要类型

根据技术细分，成像技术是 2024 年的领先技术

根据最终用户细分，医院是 2024 年的领先技术

从地区来看，北美是 2024 年最大的收入来源

甲状腺癌诊断市场-細項分析：

全球甲状腺癌诊断市场根据产品、类型、技术、最终用户和地区进行细分。

市场依产品细分为三类：仪器、试剂盒及耗材。仪器是市场成长的先驱。仪器是甲状腺癌诊断市场成长的主要驱动力，因为它们在促进准确且有效率地检测甲状腺恶性肿瘤方面发挥着重要作用。这些设备包括先进的影像系统、分子诊断工具和活检设备，在临床环境中的应用日益广泛，以提高诊断准确性。它们能够辅助早期诊断并追踪病情进展，在甲状腺癌的管理中发挥着至关重要的作用，从而推动了医院、诊断中心和研究实验室对它们的需求。

市场依类型分为两类：乳头状癌、滤泡状癌和其他。乳头状癌引领市场成长。它在甲状腺癌诊断市场中占有重要份额，占确诊病例的大多数，因为它在所有类型的甲状腺癌中发病率很高。该亚型的发病率不断上升，尤其是在女性和医疗体系发达的地区，这极大地刺激了对精准早期诊断解决方案的需求。这种领先地位凸显了持续改进专门针对乳头状甲状腺癌的诊断技术的必要性。

根据技术，市场可分为三个细分领域：血液检测、影像学、活检和其他。影像学技术是市场成长的主要驱动力。影像学技术在甲状腺结节和癌症的早期检测、诊断和监测中发挥重要作用，极大地促进了甲状腺癌诊断市场的扩张。超音波、电脑断层扫描 (CT)、磁振造影 (MRI) 和正子断层扫描 (PET) 等技术因其非侵入性特性以及提供详细解剖和功能资讯的能力而被广泛应用。在这些技术中，超音波是最常用的初步评估技术。

根据最终用户，市场可分为三个部分：医院、癌症诊断中心、学术和研究机构以及其他。医院凭藉其广泛的诊断基础设施和尖端医疗技术，处于市场成长的前沿。作为癌症筛检、诊断和治疗的主要机构，医院配备了影像系统、分子诊断工具和活检设备，这些对于精准检测甲状腺癌至关重要。患者数量的不断增加、专业医疗保健专业人员的增加以及多学科护理方法的采用，进一步增强了医院环境中对甲状腺癌诊断的需求。此外，医疗支出的成长和医院诊断能力的提升也促进了市场的扩张。

甲状腺癌诊断市场—地理洞察

北美在市场成长方面处于领先地位，这主要得益于癌症诊断技术的进步。该地区拥有完善的医疗基础设施、广泛的先进成像系统以及对下一代定序 (NGS) 和 PCR 等分子诊断工具的广泛采用。仅在美国，新诊断病例和死亡人数估计分别为 190 万和 609,360 人。现有癌症诊断方法（包括正子断层扫描 (PET)、X 光电脑断层扫描 (CT) 和磁振造影 (MRS)）以及分子诊断技术的应用提高了早期发现率，不仅在癌症患者的治疗管理中发挥着至关重要的作用，而且在癌症本身的早期识别中也发挥着至关重要的作用。在高认知度、强大的医疗保健系统和优惠政策的支持下，欧洲是市场成长第二大的地区。

甲状腺癌诊断市场-竞争格局：

甲状腺癌诊断市场竞争激烈，既有知名诊断领导者、专业生技公司，也有新兴新创公司。各公司不断创新，力求提高诊断精准度、缩短週转时间并拓展地域覆盖范围。主要参与者正将资源投入新一代定序 (NGS)、人工智慧增强成像和分子诊断领域，以确保竞争优势。一些知名公司也正进军亚太、拉丁美洲和中东等新兴市场，以利用甲状腺癌发病率不断上升以及医疗基础设施投资不断增加的优势。

最新动态：

赛默飞世尔科技公司宣布，其体外诊断测试 Oncomine 已获得美国食品药物管理局 (FDA) 的批准，可用作 2 级 IDH 突变型胶质瘤的伴随诊断。

2021 年 8 月 3 日——NorthStar Medical Radioisotopes, LLC 是用于医学成像和治疗目的的放射性药物的创新、生产和商业化的全球领导者，该公司与 GE Healthcare 今天宣布建立独家协议，在美国製造和分销碘-123 (I-123) 胶囊。

目录

第一章：甲状腺癌诊断市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 甲状腺癌诊断市场产品片段
    • 甲状腺癌诊断市场片段（按类型）
    • 甲状腺癌诊断市场（按技术）
    • 甲状腺癌诊断市场（按最终用户）摘要
    • 甲状腺癌诊断市场（按国家/地区）
    • 甲状腺癌诊断市场（按地区）
  • 竞争洞察

第三章：甲状腺癌诊断关键市场趋势

  • 甲状腺癌诊断市场驱动因素
    • 市场驱动因素的影响分析
  • 甲状腺癌诊断市场限制
    • 市场限制的影响分析
  • 甲状腺癌诊断市场机会
  • 甲状腺癌诊断市场未来趋势

第四章：甲状腺癌诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：甲状腺癌诊断市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：甲状腺癌诊断市场模式

  • 2024年甲状腺癌诊断市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：甲状腺癌诊断市场－依产品

  • 概述
    • 按产品细分的市占率分析
    • 仪器
    • 套件和耗材

第 8 章：甲状腺癌诊断市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 乳头状癌
    • 滤泡性癌
    • 其他

第九章：甲状腺癌诊断市场—依技术

  • 概述
    • 按技术分类的细分市场占有率分析
    • 验血
    • 影像学
    • 活检
    • 其他

第 10 章：甲状腺癌诊断市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院
    • 癌症诊断中心
    • 学术和研究机构
    • 其他

第 11 章：甲状腺癌诊断市场 - 按地理划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美甲状腺癌诊断主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按产品）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按技术）
    • 北美市场规模及预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲甲状腺癌诊断主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（按产品）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模及预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区甲状腺癌诊断主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品）
    • 亚太地区市场规模及预测（按类型）
    • 亚太地区市场规模及预测（依技术）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲甲状腺癌诊断主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按产品）
    • 拉丁美洲市场规模及预测（按类型）
    • 拉丁美洲市场规模及预测（按技术）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲甲状腺癌诊断主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（依产品）
    • MEA 市场规模和预测（按类型）
    • MEA 市场规模及预测（依技术）
    • MEA 市场规模及预测（依最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 12 章：甲状腺癌诊断产业主要供应商分析

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd (Roche Diagnostics)
    • Siemens Healthineers
    • Thermo Fisher Scientific
    • GE HealthCare
    • Bio-Rad Laboratories
    • Agilent Technologies
    • Philips Healthcare
    • Illumina, Inc.
    • Daiichi Sankyo
    • Hologic, Inc.
    • Becton Dickinson
    • PerkinElmer, Inc.
    • Qiagen NV
    • Veracyte, Inc.
    • Exact Sciences
    • NeoGenomics
    • DiaSorin SpA
    • Guardant Health
    • Myriad Genetics
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5448

REPORT HIGHLIGHT

Thyroid Cancer Diagnostics Market size was valued at US$ 3,167.24 Million in 2024, expanding at a CAGR of 5.5% from 2025 to 2032.

The diagnosis of thyroid cancer encompasses a thorough array of tests aimed at identifying and verifying the existence of cancer in the thyroid gland. This process includes physical assessments, blood analyses, imaging methods, biopsy techniques, and molecular or genetic evaluations. Timely and precise diagnosis is crucial for formulating effective treatment strategies and management, greatly enhancing patient outcomes and long-term survival rates. Sophisticated diagnostic instruments are vital in facilitating the prompt detection and categorization of thyroid tumors, allowing for personalized and targeted treatment options.

Thyroid Cancer Diagnostics Market- Market Dynamics

The increasing prevalence of thyroid cancer is anticipated to drive the growth of the market.

As the incidence of thyroid cancers continues to increase, there is a significant rise in the need for early and precise diagnostic solutions. This development is resulting in higher adoption of sophisticated imaging methods, molecular diagnostics, and minimally invasive biopsy techniques, all of which are crucial for effective disease identification, categorization, and treatment strategy formulation. Approximately 53,000 individuals in the United States are diagnosed with thyroid cancer annually. The treatment outcomes for the majority of thyroid cancers are quite favorable. Nevertheless, around 2,000 individuals succumb to the disease each year. Additionally, the rise in healthcare expenditures and screening initiatives presents a growth opportunity for the market. However, the high costs associated with advanced diagnostic tools pose a challenge to market expansion.

Thyroid Cancer Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2025-2032)

Based on Product segmentation, Instruments was predicted to show maximum market share in the year 2024

Based on Type segmentation, Papillary carcinoma was the leading Type in 2024

Based on Technique segmentation, the Imaging Technique was the leading Technique in 2024

Based on End-User segmentation, Hospitals were the leading Technique in 2024

Based on region, North America was the leading revenue generator in 2024

Thyroid Cancer Diagnostics Market- Segmentation Analysis:

The Global Thyroid Cancer Diagnostics Market is segmented based on Product, Type, Technique, End-User, and Region.

The market is segmented into three categories according to Product: Instruments, Kits, and consumables. Instruments are at the forefront of market growth. Instruments are the primary drivers of growth in the Thyroid Cancer Diagnostics market due to their essential function in facilitating accurate and efficient detection of thyroid malignancies. These devices, which encompass advanced imaging systems, molecular diagnostic tools, and biopsy equipment, are being increasingly utilized in clinical environments to improve diagnostic accuracy. Their capability to aid in early diagnosis and track disease progression has rendered them crucial in the management of thyroid cancer, thus propelling their demand in hospitals, diagnostic centers, and research laboratories.

The market is segmented into two categories according to Type: Papillary carcinoma, Follicular carcinoma, and others. Papillary carcinoma leads the growth of the market. It holds a significant share in the Thyroid Cancer Diagnostics market, representing the majority of diagnosed cases due to its high prevalence among all types of thyroid cancer. The increasing incidence of this subtype, especially among women and in areas with developed healthcare systems, has greatly fueled the demand for precise and early diagnostic solutions. This leadership underscores the necessity for ongoing improvements in diagnostic technologies specifically designed for papillary thyroid carcinoma.

The market is categorized into three segments based on Technique: Blood test, Imaging, Biopsy, and Other. The Imaging Technique is the primary driver of market growth. Imaging techniques significantly contribute to the expansion of the Thyroid Cancer Diagnostics market, propelled by their essential function in the early detection, diagnosis, and monitoring of thyroid nodules and cancers. Modalities such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) are extensively employed due to their non-invasive characteristics and their capacity to deliver detailed anatomical and functional information. Among these modalities, ultrasound is the most frequently utilized technique for initial assessment.

The market is categorized into three segments based on End-User: Hospitals, Cancer diagnostic centers, Academic and research institutes, and others. Hospitals are at the forefront of market growth due to their extensive diagnostic infrastructure and access to cutting-edge medical technologies. As the primary facilities for cancer screening, diagnosis, and treatment, hospitals are equipped with imaging systems, molecular diagnostic tools, and biopsy equipment that are crucial for the precise detection of thyroid cancer. The increasing influx of patients, the presence of specialized healthcare professionals, and the adoption of multidisciplinary care approaches further enhance the demand for thyroid cancer diagnostics within hospital environments. Moreover, the rise in healthcare spending and advancements in hospital-based diagnostic capabilities are also contributing to the expansion of the market.

Thyroid Cancer Diagnostics Market- Geographical Insights

North America leads in market growth, primarily due to advancements in cancer diagnostic technologies. The region has a well-established healthcare infrastructure, extensive access to advanced imaging systems, and a strong uptake of molecular diagnostic tools such as next-generation sequencing (NGS) and PCR. In the United States alone, the estimated figures for new diagnoses and deaths stand at 1.9 million and 609,360, respectively. The application of existing cancer diagnostic methods, including positron emission tomography (PET), X-ray computed tomography (CT), and magnetic resonance spectroscopy (MRS), along with molecular diagnostic techniques, has facilitated early detection rates and plays a crucial role not only in the therapeutic management of cancer patients but also in the early identification of cancer itself. Europe ranks as the second-largest region for market growth, supported by high awareness, strong healthcare systems, and favorable policies.

Thyroid Cancer Diagnostics Market- Competitive Landscape:

The market for thyroid cancer diagnostics is marked by fierce competition among well-established diagnostic leaders, specialized biotechnology companies, and new startups. Firms are persistently innovating to improve diagnostic precision, shorten turnaround times, and broaden their geographical reach. Major players are allocating resources toward next-generation sequencing (NGS), AI-enhanced imaging, and molecular diagnostics to secure a competitive advantage. Prominent companies are also venturing into emerging markets such as Asia-Pacific, Latin America, and the Middle East to take advantage of the growing incidence of thyroid cancer and the increased investment in healthcare infrastructure.

Recent Developments:

Thermo Fisher Scientific has announced that its in vitro diagnostic test, Oncomine, has been granted approval by the US Food and Drug Administration (FDA) for use as a companion diagnostic in grade 2 IDH-mutant glioma.

August 3, 2021 - NorthStar Medical Radioisotopes, LLC, a worldwide leader in the innovation, production, and commercialization of radiopharmaceuticals utilized for medical imaging and therapeutic purposes, along with GE Healthcare, has today declared the establishment of an exclusive agreement for the manufacturing and distribution of iodine-123 (I-123) capsules within the United States.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THYROID CANCER DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd (Roche Diagnostics)
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • GE HealthCare
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Philips Healthcare
  • Illumina, Inc.
  • Daiichi Sankyo
  • Hologic, Inc.
  • Becton Dickinson
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Veracyte, Inc.
  • Exact Sciences
  • NeoGenomics
  • DiaSorin S.p.A.
  • Guardant Health
  • Myriad Genetics
  • Others

GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Instruments
  • Kits & consumables

GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Papillary carcinoma
  • Follicular carcinoma
  • Other

GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032

  • Blood test
  • Imaging
  • Biopsy
  • Other

GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Cancer diagnostic centers
  • Academic and research institutes
  • Other

GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Thyroid Cancer Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Thyroid Cancer Diagnostics Market Snippet by Product
    • 2.1.2. Thyroid Cancer Diagnostics Market Snippet by Type
    • 2.1.3. Thyroid Cancer Diagnostics Market Snippet by Technique
    • 2.1.4. Thyroid Cancer Diagnostics Market Snippet by End-User
    • 2.1.5. Thyroid Cancer Diagnostics Market Snippet by Country
    • 2.1.6. Thyroid Cancer Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Thyroid Cancer Diagnostics Key Market Trends

  • 3.1. Thyroid Cancer Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Thyroid Cancer Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Thyroid Cancer Diagnostics Market Opportunities
  • 3.4. Thyroid Cancer Diagnostics Market Future Trends

4. Thyroid Cancer Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Thyroid Cancer Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Thyroid Cancer Diagnostics Market Landscape

  • 6.1. Thyroid Cancer Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Thyroid Cancer Diagnostics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Instruments
    • 7.1.3. Kits & consumables

8. Thyroid Cancer Diagnostics Market - By Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 8.1.2. Papillary carcinoma
    • 8.1.3. Follicular carcinoma
    • 8.1.4. Other

9. Thyroid Cancer Diagnostics Market - By Technique

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technique, 2024 & 2032 (%)
    • 9.1.2. Blood test
    • 9.1.3. Imaging
    • 9.1.4. Biopsy
    • 9.1.5. Other

10. Thyroid Cancer Diagnostics Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Cancer diagnostic centers
    • 10.1.4. Academic and research institutes
    • 10.1.5. Other

11. Thyroid Cancer Diagnostics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Thyroid Cancer Diagnostics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Thyroid Cancer Diagnostics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Thyroid Cancer Diagnostics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Thyroid Cancer Diagnostics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Thyroid Cancer Diagnostics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Thyroid Cancer Diagnostics Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. F. Hoffmann-La Roche Ltd (Roche Diagnostics)
    • 12.2.3. Siemens Healthineers
    • 12.2.4. Thermo Fisher Scientific
    • 12.2.5. GE HealthCare
    • 12.2.6. Bio-Rad Laboratories
    • 12.2.7. Agilent Technologies
    • 12.2.8. Philips Healthcare
    • 12.2.9. Illumina, Inc.
    • 12.2.10. Daiichi Sankyo
    • 12.2.11. Hologic, Inc.
    • 12.2.12. Becton Dickinson
    • 12.2.13. PerkinElmer, Inc.
    • 12.2.14. Qiagen N.V.
    • 12.2.15. Veracyte, Inc.
    • 12.2.16. Exact Sciences
    • 12.2.17. NeoGenomics
    • 12.2.18. DiaSorin S.p.A.
    • 12.2.19. Guardant Health
    • 12.2.20. Myriad Genetics
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us